1966
DOI: 10.1210/endo-78-1-225
|View full text |Cite
|
Sign up to set email alerts
|

Ovulatory Failure in Rats After Treatment with Brain Norepinephrine Depletors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
2

Year Published

1967
1967
1982
1982

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(15 citation statements)
references
References 0 publications
0
13
2
Order By: Relevance
“…It also provides an explanation for the in vitro effect of 5-HT reported by M oszkowska, who has shown that the amine antagonizes the gonadotropic releasing activity of hypothalamic fragments incubated with adenohypophyscal tissue [25]; in this particular instance, 5-HT is more likely to affect the release of LRF present in the hypotha lamic tissue, rather than the physiological activity in the incubated brain fragments. Surprisingly, decreased brain catecholamine levels following a-MT treatment did not affect ovulation under our experimental conditions, in contrast to the findings reported by other authors [4,5,18]. This divergence of opinion could be due to differences in the route of administration; in the experiments cited, the results were obtained after intraperitoneal a-MT, whereas we gave it per os, since the ingested drug is less toxic [24] and seems equally potent in blocking NA synthesis [15,24].…”
Section: Discussioncontrasting
confidence: 80%
See 1 more Smart Citation
“…It also provides an explanation for the in vitro effect of 5-HT reported by M oszkowska, who has shown that the amine antagonizes the gonadotropic releasing activity of hypothalamic fragments incubated with adenohypophyscal tissue [25]; in this particular instance, 5-HT is more likely to affect the release of LRF present in the hypotha lamic tissue, rather than the physiological activity in the incubated brain fragments. Surprisingly, decreased brain catecholamine levels following a-MT treatment did not affect ovulation under our experimental conditions, in contrast to the findings reported by other authors [4,5,18]. This divergence of opinion could be due to differences in the route of administration; in the experiments cited, the results were obtained after intraperitoneal a-MT, whereas we gave it per os, since the ingested drug is less toxic [24] and seems equally potent in blocking NA synthesis [15,24].…”
Section: Discussioncontrasting
confidence: 80%
“…Since neither increased nor decreased local catecholamine levels interfered with ovulation under our experimental conditions, we cannot add any further evidence as to the role of catecholaminergic systems in LH control, which has been postulated by various authors [4,5,12,18,29]; cholinergic mechanisms have, equally, been reported to affect LH release [2,29,31], at still undetermined levels of the complex structures controlling gonadotropic regulation [14].…”
Section: Discussionmentioning
confidence: 89%
“…However, Coppola et al(1966) and Lippmann et al(1967) stated that when hypothalamic catecholamines were reduced by systemic injection of some pharmacological drugs, ovulation was suppressed. Kordon and Glowinski (1969) have also shown using cxmethyl-p-tyrosine, an inhibitor of catecholamine synthesis, that DA is necessary for ovulation of the rat at a critical time of the day of proestrus.…”
Section: Discussionmentioning
confidence: 99%
“…Reserpine also inhibits ovulation induced by pregnant mare's serum (PMS) in immature mice [B row n, 1966] and in immature rats [Coppola et at., 1966]. In the latter case, the inhibition is partiallyreversed by prior administration of the MAOI, iproniazid, or by subsequent treatment with human chorionic gonadotrophin (HCG).…”
Section: Pargyline Reserpine Human Chorionic Gonadotrophin Pregnant Mmentioning
confidence: 99%